| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2015 | An anti-EpCAM antibody EpAb2-6 for the treatment of colon cancer | Liao, M. Y.; Lai, J. K.; Kuo, M. Y. P.; Lu, R. ; Lin, C. W.; Cheng, P. C.; Liang, K. H.; Wu, H. C. | Oncotarget 6(28), 24947-24968 | | | |
| 2020 | EpCAM signaling promotes tumor progression and protein stability of PD-L1 through EGFR pathway | Chen, H. N.; Liang, K. H.; Lai, J. K.; Lan, C. H.; Liao, M. Y.; Hung, S. H.; Chuang, Y. T.; Chen, K. C.; Tsuei, W. W. F.; Wu, H. C. | Cancer Research 80(22), 5035-5050 | | | |
| 2017 | EpCAM/EpEX Regulate Tumor Progression through EGFR Signaling in Colon Cancer Cells | Liang, K. H.; Lai, J. K.; Kuan, I. I.; Tso, H. C.; Wu, H. C. | | | | |
| 2018 | Extracellular domain of EpCAM enhances tumor progression through EGFR signaling in colon cancer cells | Liang, K. H.; Tso, H. C.; Hung, S. H.; Kuan, I. I.; Lai, J. K.; Ke, F. Y.; Chuang, Y. T.; Liu, I. J.; Wang, Y. P.; Chen, R. H.; Wu, H. C. | Cancer Letters 433, 165-175 | | | |
